Global Bioinformatics Industry

  • July 2014
  • -
  • Global Industry Analysts
  • -
  • 353 pages

This report analyzes the worldwide markets for Bioinformatics in US$ Million by the following Product Segments: Software, Hardware, and Biocontent. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles121 companies including many key and niche players such as -

3rd Millennium, Inc.
Affymetrix, Inc.
Agilent Technologies
Dassault Systèmes
Geneva Bioinformatics S.A

Table Of Contents




I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-2
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3
Software I-3
Hardware I-3
Biocontent I-3


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
Bioinformatics: An Introductory Prelude II-1
Current and Future Analysis II-2
Analysis by Region II-4
Analysis by Segment II-4
Growth Drivers in a Gist II-4
Market Restraints II-5
Bioinformatics: A Critical Drug Discovery Tool II-5
Role of Proteomics II-6
Industry Challenges II-7
Industry Structure II-8
Consolidation - A Key to Success II-8

2. BIOINFORMATICS TOOLS/SOFTWARE/ PROJECTS/DATABASES II-9
List of Select Bioinformatics Tools and Software II-9
List of Bioinformatics Projects II-11
List of Bioinformatics Databases by Category II-11
List of Select Open-Source Bioinformatics Tools/Software II-13

3. MAJOR TRENDS AND ISSUES II-14
Impact of the Economic Recession on the Life Sciences Industry
in Retrospect II-14
2D Gel Electrophoresis Market Gains Grounds II-14
Role of Contract Research Organizations - All Set to Increase
in Proteomics II-15
Efforts on Developing Rapid and Easy Genetic Data Analysis
Solutions Rampant II-15
Mobile-Based Technologies Gains Traction in RandD Operations II-16
Smartphone Bringing a New Dawn in Laboratory Management II-16
Bioinformatics Bringing a Paradigm Shift in Genetic Research II-17
Challenges Faced in Prosecuting Bioinformatics Patent
Applications II-17
India - Global Hub for Outsourced Bioinformatics Services II-18
China All Set To Play a Major Role in the Proteomics Industry II-19
Importance of IP Protection Systems in Bioinformatics II-19
Issue of Data Analysis Still Looms Large II-20
Bioinformatics Clouds: A Potential Solution II-21
Cloud-based Services in Bioinformatics II-23
Data as a Service (DaaS) II-23
Platform as a Service (PaaS) II-24
Software as a Service (SaaS) II-24
Infrastructure as a Service (IaaS) II-24
Illustration of Bioinformatics Cloud II-24
Cloud Resources in Bioinformatics II-25

4. A REVIEW OF END-USE MARKETS/ APPLICATIONS II-26
Bioinformatics: Crucial for New Drug Development II-26
Opportunities in Personalized Medicine and Clinical Trial
Services II-26
Bioinformatics Gain Prominence in Biomarkers Discovery II-27
Bioinformatics in Cancer Research: Promising Potential II-28
Table 1: World Cancer Incidence by Geographic Region and
Gender (2012): Number of New Cancer Cases Reported (in
Thousands) for Asia-Oceania, Europe, North America, Latin
America and The Caribbean, and Africa (includes corresponding
Graph/Chart) II-30

Table 2: New Cancer Cases in the World by Affected Site
(2012) (in Thousands) (includes corresponding Graph/Chart) II-30
Application of Bioinformatics to Oral Genomics II-31
Proteomics Charges up the Market II-31
Data Validation - A Burning Issue II-31
Standardization and Consistency - A Prime Concern II-32
Role of Chemoinformatics Tools in Drug Design II-32
A List of Select Chemical Structure Drawing Tools and Data Bases II-33
Bioinformatics Gaining Foothold in Metabolomics Research II-33
Biotechnology and Pharmaceutical Sectors Drive Metabolomics
Research II-34
Demand for Metabolomic Data Analysis Tools and Software on Rise II-34
Other Applications II-35
Transcriptomics II-35
Molecular Phylogenetics Research II-35
CADD Research II-35
New Applications Brightens Opportunities II-36

5. INTRODUCTION TO BIOINFORMATICS II-37
Bioinformatics: Definition II-37
Bioinformatics: History in Brief II-37
Functions of Bioinformatics II-38
Major End-Users of Bioinformatics II-38
Interface of IT and Biosciences II-38
Venture Capital and Bioinformatics II-39
Branches Associated with Bioinformatics II-39
Emerging Clinical Genomics Industry II-39
Genomic Business Models II-39

6. INSIGHT INTO BIOINFORMATICS TECHNOLOGY II-40
Protein Structure and its Determination II-40
Components of Bioinformatics II-40
Software II-40
Hardware II-40
Biocontent II-40
Proteins/Proteomics Data and Databases II-40
DNA Sequences and Protein Sequencing II-41
Aligning Sequences II-41
Databases II-41
Nucleotide Databases II-41
EMBL Nucleotide Sequence Database II-41
DNA Database of Japan (DDBJ) II-42
GenBank II-42
Institute for Genomic Research (TIGR) II-42
Protein Databases II-42
SWISS-PROT II-42
TrEMBL II-43
IMGT/LIGM-DB II-43
PROSITE II-43
Design and Development of XML Bioinformatics Environment II-43
Biopolymer Markup Language (BioML) II-43
Bioinformatics Sequence Mark-Up Language - BSML II-43
Genome Annotation Markup Elements (GAME) II-43
Microarray Markup Language (MAML) II-44
Gene Expression Markup Language (GEMLâ„¢) II-44
Hardware II-44
Technologies Involved II-44
Computer-Assisted Imaging, Mapping and High-Throughput
Screening II-44
Database Engineering II-44
Computer Processing II-44
Computational Software II-44

7. PRODUCT INNOVATIONS/INTRODUCTIONS II-45
Agilent Technologies Releases Advanced Modeling Solutions for
High-Frequency/High-Power GaN HEMTs and Nanoscale 3D FinFETs II-45
Agilent Technologies Launches QuikChange HT Protein
Engineering System II-45
Affymetrix and BioDiscovery Introduce New Copy Number Analysis
Software Solution II-45
Agilent Technologies Launches SureSelectQXT Target Enrichment
Kits II-45
Qiagen Expands its Portfolio of Bioinformatics Solutions II-45
Agilent Technologies Launches OpenLAB CDS A.02.01 II-45
Life Technologies Launches Oncomine NGS RNA-Seq Gene
Expression Browser II-46
Qiagen Launches QIAxpert® System and CLC Bioinformatics Suite
for Cancer Research II-46
Waters Corporation Releases Two New Data Analysis Software
Packages II-46
Agilent Technologies Releases SureCall Version 2.0 Software II-46
Agilent Technologies Launches MassHunter Profinder Software II-46
Affymetrix Rolls Out New OncoScanâ„¢ FFPE Assay Kit II-46
Agilent Technologies Launches Agilent MassHunter All Ions MS/
MS and MassHunter BioConfirm Programs II-47
Illumina Introduces BaseSpace® Apps II-47
Agilent Technologies Releases OpenLAB Data Store for Mass
Spectrometry II-47
Agilent Technologies Launches LC Dissolution Software II-47
Arpeggi Introduces Genome Comparison and Analytic Testing Tool II-47
Agilent Technologies Releases VnmrJ 4.0 II-47
Life Technologies Releases Vector NTI® Express Designer II-48
Life Technologies Introduces Oncomine® Gene Browser and Ion
Reporter™ Oncomine® Workflow II-48
Cofactor Genomics Introduces Online Bioinformatics Solution II-48
DNA2.0 Launches Custom Bioinformatics Services II-48
Genome Designs Partners with SciDM Group II-48
BGI Powers EasyGenomics with Aspera’s fasp High-Speed File
Transfer Technology II-48
IDBS Adds New Functionality to ChemBook ELN II-49
Agilent Introduces New Agilent GPC/SEC Software for Gel
Permeation/Size Exclusion Chromatography II-49
Agilent Technologies Introduces GeneSpring 12.0 II-49
Kitware Releases Visomics Open-Source Bioinformatics Application II-49
Eureka Genomics Launches 16S Metagenomics Analysis Service II-49
Agilent Technologies Expands SureSelect Target- Enrichment System II-49

8. RECENT INDUSTRY ACTIVITY II-50
SCORR Marketing Enters into Strategic Alliance with
BioInformatics II-50
Agilent Technologies and PREMIER Biosoft Couple Hardware-
Software Platforms to Assist Researchers in Glycomics II-50
Agilent Technologies to Distribute MassWorks Calibration and
Analysis Software of Cerno Bioscience with Agilent GC/MSD
Systems II-50
The Jackson Laboratory and Wuhan Frasergen Bioinformatics
Jointly Build Cancer Genomics Facility II-50
Dassault Systemes Launches New BIOVIA Brand II-50
Biomax Informatics and KWS SAAT Extend Software License Agreement II-51
Dassault Systemes Announces Acquisition of Accelrys II-51
Rancho BioSciences Partners with IDBS II-51
The Philippine Genome Center to Launch New Bioinformatics
Facility II-51
IDBS Enters into Strategic Alliance with Osthus to Support
Customer RandD II-51
Thermo Fisher Scientific Acquires Life Technologies II-51
QIAGEN Acquires CLC bio II-51
Illumina Acquires NextBio II-52
Evonik Expands Collaboration with Genedata II-52
Waters Takes Over Nonlinear Dynamics II-52
Gene by Gene Takes Over Arpeggi II-52
OpGen Enters into Strategic Alliance with Applied Maths II-52
McMaster and Cisco Join Forces on Bioinformatics Cloud Computing II-52
Qiagen Acquires Ingenuity Systems II-53
BGI-Shenzhen Acquires of Complete Genomics II-53
PREMIER Biosoft Acquires ProteoIQ MS Software Business II-53
Affymetrix Selects GenoSplice as Its Preferred Data Analysis
Service Provider II-53
The SIB Swiss Institute of Bioinformatics, GeneBio and Quartz
Bio Collaborate II-53
Curie-Cancer Enters into Bioinformatics Partnership Agreement
with GenoSplice Technology II-53
MOgene Partners with Intuitive Genomics II-53
Boston Children's Hospital Partners Life Technologies II-54
IDBS Offers E-WorkBook to Seattle Genetics II-54
Agilent Technologies Enters into Licensing Agreement with SRI
International II-54
Transformatix Technologies Partners with NCH to Establish BioLinQ II-54
KineMatik and Scilligence Enter into Strategic Alliance II-54
Life Technologies Takes Over Compendia Bioscience II-54
CLC bio Takes Over Molegro II-55
IDBS Enters into Partnership with Thomson Reuters II-55
Partek Partners with Life Technologies II-55
Cofactor Genomics Enters into Partnership with Intrepid
Bioinformatics II-55

9. FOCUS ON SELECT PLAYERS II-56
3rd Millennium, Inc. (US) II-56
Affymetrix, Inc. (US) II-56
Agilent Technologies (US) II-57
Dassault Systemes (France) II-57
Geneva Bioinformatics S.A (Switzerland) II-58
ID Business Solutions Ltd. (UK) II-58
Instem plc (UK) II-59
Life Technologies (US) II-59
Illumina, Inc. (US) II-60
Kinexus Bioinformatics Corporation (Canada) II-61
Nonlinear Dynamics, Ltd. (UK) II-61
Ocimum Biosolutions Ltd. (India) II-61
Gene Logic (US) II-62
PerkinElmer Inc. (US) II-62
QIAGEN N.V. (The Netherlands) II-63
CLC bio (Denmark) II-64
Strand Life Sciences (India) II-64

10. GLOBAL MARKET PERSPECTIVE II-65
Table 3: World Recent Past, Current and Future Analysis for
Bioinformatics by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) II-65

Table 4: World Historic Review for Bioinformatics by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,
Latin America and Rest of World Markets Independently Analyzed
with Annual Revenue Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) II-66

Table 5: World 15-Year Perspective for Bioinformatics by
Geographic Region - Percentage Breakdown of Revenues for US,
Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of
World Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) II-67
Analytics by Product Segment II-68
Table 6: World Recent Past, Current and Future Analysis for
Software (Bioinformatics) by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific, Latin America and Rest of World
Markets Independently Analyzed with Annual Revenue Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-68

Table 7: World Historic Review for Software (Bioinformatics)
by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-69

Table 8: World 15-Year Perspective for Software
(Bioinformatics) by Geographic Region - Percentage Breakdown
of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin
America and Rest of World Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) II-70

Table 9: World Recent Past, Current and Future Analysis for
Biocontent (Bioinformatics) by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific, Latin America and Rest of World
Markets Independently Analyzed with Annual Revenue Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-71

Table 10: World Historic Review for Biocontent
(Bioinformatics) by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-72

Table 11: World 15-Year Perspective for Biocontent
(Bioinformatics) by Geographic Region - Percentage Breakdown
of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin
America and Rest of World Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) II-73

Table 12: World Recent Past, Current and Future Analysis for
Hardware (Bioinformatics) by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific, Latin America and Rest of World
Markets Independently Analyzed with Annual Revenue Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-74

Table 13: World Historic Review for Hardware (Bioinformatics)
by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-75

Table 14: World 15-Year Perspective for Hardware
(Bioinformatics) by Geographic Region - Percentage Breakdown
of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin
America and Rest of World Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) II-76


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Market Overview III-1
Patents in Bioinformatics III-1
Personalized Medicine Market in the US - A Review III-2
FDA’s Antidote III-2
Product Launches III-3
Strategic Corporate Developments III-7
Key Players III-11
B.Market Analytics III-15
Table 15: The US Recent Past, Current and Future Analysis for
Bioinformatics by Product Segment - Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-15

Table 16: The US Historic Review for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-16

Table 17: The US 15-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Revenues for
Software, Biocontent and Hardware Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-17

2. CANADA III-18
A.Market Analysis III-18
Current and Future Analysis III-18
Bioinformatics in Recombinant Technology III-18
Canadian Bioinformatics Industry III-18
Strategic Corporate Development III-19
Kinexus Bioinformatics Corporation - A Key Player III-19
B.Market Analytics III-20
Table 18: Canadian Recent Past, Current and Future Analysis
for Bioinformatics by Product Segment - Software, Biocontent
and Hardware Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2013 through 2020
(includes corresponding Graph/Chart) III-20

Table 19: Canadian Historic Review for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-21

Table 20: Canadian 15-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Revenues for
Software, Biocontent and Hardware Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-22

3. JAPAN III-23
A.Market Analysis III-23
Current and Future Analysis III-23
Japanese Bioinformatics Industry - An Overview III-23
JBiC Drives Japanese Bioinformatics Industry III-23
B.Market Analytics III-24
Table 21: Japanese Recent Past, Current and Future Analysis
for Bioinformatics by Product Segment - Software, Biocontent
and Hardware Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2013 through 2020
(includes corresponding Graph/Chart) III-24

Table 22: Japanese Historic Review for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-25

Table 23: Japanese 15-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Revenues for
Software, Biocontent and Hardware Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-26

4. EUROPE III-27
A.Market Analysis III-27
Current and Future Analysis III-27
European Bioinformatics Market III-27
New Investments to Stimulate Bioinformatics Sector III-27
Proteomics Research in Europe - An Overview III-28
Table 24: European Proteomics Market (2013): Percentage
Breakdown of Deployment of Proteomics Technologies in
End-Use Segment - Research and Academic Institutions,
Pharmaceutical Companies, and Clinical Laboratories
(includes corresponding Graph/Chart) III-29
European Personalized Medicine Market to Exhibit Robust Growth III-29
Major Public Science Institutes III-29
Regulatory Environment III-29
B.Market Analytics III-30
Table 25: European Recent Past, Current and Future Analysis
for Bioinformatics by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-30

Table 26: European Historic Review for Bioinformatics by
Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets Independently Analyzed
with Annual Revenue Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-31

Table 27: European 15-Year Perspective for Bioinformatics by
Geographic Region - Percentage Breakdown of Revenues for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-32

Table 28: European Recent Past, Current and Future Analysis
for Bioinformatics by Product Segment - Software, Biocontent
and Hardware Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2013 through 2020
(includes corresponding Graph/Chart) III-33

Table 29: European Historic Review for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-34

Table 30: European 15-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Revenues for
Software, Biocontent and Hardware Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-35

4a. FRANCE III-36
A.Market Analysis III-36
Current and Future Analysis III-36
Strategic Corporate Development III-36
Dassault Systemes - A Key Player III-36
B.Market Analytics III-38
Table 31: French Recent Past, Current and Future Analysis for
Bioinformatics by Product Segment - Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-38

Table 32: French Historic Review for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-39

Table 33: French 15-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Revenues for
Software, Biocontent and Hardware Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-40

4b. GERMANY III-41
A.Market Analysis III-41
Current and Future Analysis III-41
Strategic Corporate Development III-41
B.Market Analytics III-42
Table 34: German Recent Past, Current and Future Analysis for
Bioinformatics by Product Segment - Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-42

Table 35: German Historic Review for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-43

Table 36: German 15-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Revenues for
Software, Biocontent and Hardware Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-44

4c. ITALY III-45
Market Analysis III-45
Table 37: Italian Recent Past, Current and Future Analysis for
Bioinformatics by Product Segment - Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-45

Table 38: Italian Historic Review for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-46

Table 39: Italian 15-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Revenues for
Software, Biocontent and Hardware Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-47

4d. THE UNITED KINGDOM III-48
A.Market Analysis III-48
Current and Future Analysis III-48
Research Entities III-48
UK Targets Leadership in Medical Genomics III-48
New Funding for Developing Tools to Encourage Industry III-49
Increased Support for Personalized Medicine to Drive
Bioinformatics Demand III-49
Product Launch III-49
Strategic Corporate Developments III-50
Key Players III-51
B.Market Analytics III-52
Table 40: The UK Recent Past, Current and Future Analysis for
Bioinformatics by Product Segment - Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-52

Table 41: The UK Historic Review for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-53

Table 42: The UK 15-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Revenues for
Software, Biocontent and Hardware Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-54

4e. SPAIN III-55
Market Analysis III-55
Table 43: Spanish Recent Past, Current and Future Analysis for
Bioinformatics by Product Segment - Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-55

Table 44: Spanish Historic Review for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-56

Table 45: Spanish 15-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Revenues for
Software, Biocontent and Hardware Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-57

4f. RUSSIA III-58
Market Analysis III-58
Table 46: Russian Recent Past, Current and Future Analysis for
Bioinformatics by Product Segment - Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-58

Table 47: Russian Historic Review for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-59

Table 48: Russian 15-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Revenues for
Software, Biocontent and Hardware Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-60

4g. REST OF EUROPE III-61
A.Market Analysis III-61
Current and Future Analysis III-61
Strategic Corporate Developments III-61
Key Players III-62
B.Market Analytics III-64
Table 49: Rest of European Recent Past, Current and Future
Analysis for Bioinformatics by Product Segment - Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-64

Table 50: Rest of European Historic Review for
Bioinformatics by Product Segment - Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-65

Table 51: Rest of European 15-Year Perspective for
Bioinformatics by Product Segment - Percentage Breakdown of
Revenues for Software, Biocontent and Hardware Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-66

5. ASIA-PACIFIC III-67
Market Analysis III-67
Table 52: Asia-Pacific Recent Past, Current and Future
Analysis for Bioinformatics by Geographic Region - China,
India and Rest of Asia-Pacific Markets Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-68

Table 53: Asia-Pacific Historic Review for Bioinformatics by
Geographic Region - China, India and Rest of Asia-Pacific
Markets Independently Analyzed with Annual Revenue Figures
in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-69

Table 54: Asia-Pacific 15-Year Perspective for
Bioinformatics by Geographic Region - Percentage Breakdown
of Revenues for China, India and Rest of Asia-Pacific
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-70

Table 55: Asia-Pacific Recent Past, Current and Future
Analysis for Bioinformatics by Product Segment - Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-71

Table 56: Asia-Pacific Historic Review for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-72

Table 57: Asia-Pacific 15-Year Perspective for
Bioinformatics by Product Segment - Percentage Breakdown of
Revenues for Software, Biocontent and Hardware Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-73

5a. CHINA III-74
A.Market Analysis III-74
Current and Future Analysis III-74
Product Launch III-74
Strategic Corporate Developments III-74
B.Market Analytics III-75
Table 58: Chinese Recent Past, Current and Future Analysis for
Bioinformatics by Product Segment - Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-75

Table 59: Chinese Historic Review for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-76

Table 60: Chinese 15-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Revenues for
Software, Biocontent and Hardware Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-77

5b. INDIA III-78
A.Market Analysis III-78
Current and Future Analysis III-78
India: Brimming with Opportunities III-78
Growth Drivers in a Nut Shell III-80
Indian Scientific Research towards Functional Genomics and
Proteomics III-80
Bioinformatics Applications in India: A Review III-81
Agricultural Biotech: The Largest Application Sector for
Bioinformatics III-81
Table 61: Bioinformatics Applications in India by Sector
(2013): Percentage Share Breakdown of Revenues for
Agricultural Biotech, Animal Biotech, Environmental
Biotech, Forensic Biotech, Medical Biotech and Others
(includes corresponding Graph/Chart) III-82
Next-Generation Sequencing Paints Brighter Prospects III-82
India - An Emerging Player in Bioinformatics Offshoring
Services III-82
Emerging Trends in the Indian Bioinformatics Services Sector III-83
Competition III-83
Table 62: Leading Players in the Bioinformatics Market in
India (2013): Percentage Breakdown of Revenues for
Molecular Connections, Ocimum Biosolutions, Strand Life
Sciences and Others (includes corresponding Graph/Chart) III-84
Key Players III-84
B.Market Analytics III-85
Table 63: Indian Recent Past, Current and Future Analysis for
Bioinformatics by Product Segment - Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-85

Table 64: Indian Historic Review for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-86

Table 65: Indian 15-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Revenues for
Software, Biocontent and Hardware Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-87

5c. REST OF ASIA-PACIFIC III-88
A.Market Analysis III-88
Current and Future Analysis III-88
Focus on Select Markets III-88
Taiwan III-88
Australia III-88
Market Drivers III-89
Market Inhibitors III-89
Singapore III-89
Korea III-89
Strategic Corporate Developments III-89
B.Market Analytics III-90
Table 66: Rest of Asia-Pacific Recent Past, Current and Future
Analysis for Bioinformatics by Product Segment - Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-90

Table 67: Rest of Asia-Pacific Historic Review for
Bioinformatics by Product Segment - Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-91

Table 68: Rest of Asia-Pacific 15-Year Perspective for
Bioinformatics by Product Segment - Percentage Breakdown of
Revenues for Software, Biocontent and Hardware Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-92

6. LATIN AMERICA III-93
A.Market Analysis III-93
Current and Future Analysis III-93
Market Overview III-93
B.Market Analytics III-94
Table 69: Latin American Recent Past, Current and Future
Analysis for Bioinformatics by Geographic Region - Brazil
and Rest of Latin American Markets Independently Analyzed
with Annual Revenue Figures in US$ Million for Years 2013
through 2020 (includes corresponding Graph/Chart) III-94

Table 70: Latin American Historic Review for Bioinformatics
by Geographic Region - Brazil and Rest of Latin American
Markets Independently Analyzed with Annual Revenue Figures
in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-95

Table 71: Latin American 15-Year Perspective for
Bioinformatics by Geographic Region - Percentage Breakdown
of Revenues for Brazil and Rest of Latin American Markets
for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-96

Table 72: Latin American Recent Past, Current and Future
Analysis for Bioinformatics by Product Segment - Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-97

Table 73: Latin American Historic Review for Bioinformatics
by Product Segment - Software, Biocontent and Hardware
Markets Independently Analyzed with Annual Revenue Figures
in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-98

Table 74: Latin American 15-Year Perspective for
Bioinformatics by Product Segment - Percentage Breakdown of
Revenues for Software, Biocontent and Hardware Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-99

6a. BRAZIL III-100
Market Analysis III-100
Table 75: Brazilian Recent Past, Current and Future Analysis
for Bioinformatics by Product Segment - Software, Biocontent
and Hardware Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2013 through 2020
(includes corresponding Graph/Chart) III-100

Table 76: Brazilian Historic Review for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-101

Table 77: Brazilian 15-Year Perspective for Bioinformatics
by Product Segment - Percentage Breakdown of Revenues for
Software, Biocontent and Hardware Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-102

6b. REST OF LATIN AMERICA III-103
Market Analysis III-103
Table 78: Rest of Latin American Recent Past, Current and
Future Analysis for Bioinformatics by Product Segment -
Software, Biocontent and Hardware Markets Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-103

Table 79: Rest of Latin American Historic Review for
Bioinformatics by Product Segment - Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-104

Table 80: Rest of Latin American 15-Year Perspective for
Bioinformatics by Product Segment - Percentage Breakdown of
Revenues for Software, Biocontent and Hardware Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-105

7. REST OF WORLD III-106
Market Analysis III-106
Table 81: Rest of World Recent Past, Current and Future
Analysis for Bioinformatics by Product Segment - Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-106

Table 82: Rest of World Historic Review for Bioinformatics
by Product Segment - Software, Biocontent and Hardware
Markets Independently Analyzed with Annual Revenue Figures
in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-107

Table 83: Rest of World 15-Year Perspective for
Bioinformatics by Product Segment - Percentage Breakdown of
Revenues for Software, Biocontent and Hardware Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-108


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 121 (including Divisions/Subsidiaries - 126)

The United States (79)
Canada (4)
Europe (33)
- France (3)
- Germany (10)
- The United Kingdom (5)
- Rest of Europe (15)
Asia-Pacific (Excluding Japan) (10)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Global Next-generation Sequencing Trends

Global Next-generation Sequencing Trends

  • $ 12 500
  • Industry report
  • September 2014
  • by Frost & Sullivan

An End-user Perspective The overall research objective was to capture and analyze global next-generation (NGS) sequencing trends and use. Most researchers outsource NGS technologies; however, in-house ...

Global Next-generation Sequencing Market

Global Next-generation Sequencing Market

  • $ 10 000
  • Industry report
  • June 2014
  • by Frost & Sullivan

On the Verge of a Quadrupled Competitor Size and a Clinical Turning Point The total market, as defined by this study, includes next-generation sequencing instruments and reagents. Instruments include those ...

Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets

Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • September 2014
  • by BCC Research

This BCC Research report discusses market growth, size and opportunities with respect to applications, geographic region and technologies. Forecast trends and revenue are given through 2019. Major players, ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.